prescription drug prices

Prescription Drug Price Bill Before Senate

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

When Congress returns next week, a bill to cut prescription drug costs will be on its plate. It was crafted by a bipartisan team, and it scaled its first hurdle in the Senate.

By: 
Lynne Terry

Crunch Time In Salem: Lawmakers Consider Must-Do Lists

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

SALEM – A legislative session marked by partisan tension is entering its final weeks with plenty of unfinished business on the health care front.

By: 
Elon Glucklich

Schrader Wants to Speed Up Approval Time for Generic Drugs

The Lower Drug Costs Through Competition Act would give the FDA six months to approve generic drugs, for which a brand name version of the active drug has already been authorized. The bill has bipartisan support, and he believes it could be passed as part of the year-end negotiations in President Obama’s lame-duck session.

U.S. Rep. Kurt Schrader has introduced legislation with bipartisan support that he believes will limit pharmaceutical profiteering and encourage manufacturers to produce generic versions of drugs for which there’s currently no competition.

By: 
Chris Gray
Subscribe to prescription drug prices